Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Medi Bone Max
- Development stage
- Unknown
- Lead developer
- Medi-Crescent Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Medi Bone Max is an oral nutritional supplement distributed by Medi-Crescent Pharma, a pharmaceutical wholesaler and distributor based in Kenya. It is formulated to support bone health and assist in the prevention of bone loss, particularly as a supportive intervention for conditions such as osteoporosis. As a dietary supplement, it is intended to provide essential micronutrients required for the maintenance of bone mineral density and skeletal integrity. The product is part of a broader portfolio of musculoskeletal health supplements marketed by Medi-Crescent Pharma to the Kenyan healthcare market.
- Brand names
- Medi Bone Max
Beyond the preview
Go deeper on Medi Bone Max.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medi Bone Max.